XenoTherapeutics Inc. and Xeno Acquisition Corp, a non-profit biotechnology company, on Friday agreed to acquire Repare Therapeutics Inc. (NASDAQ:RPTX) .Repare shareholders will receive a cash payment per Common Share, determined based on Repare’s cash balance at closing of the transaction, after deducting certain transaction costs and the aggregate amount of outstanding liabilities.Based on Repare’s current estimates, each Repare shareholder will receive a cash payment of $1.82 per Common Share.In addition ...